Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States

OSAKA, Japan, June 20, 2016 /PRNewswire/ -- Mitsubishi Tanabe Pharma Corporation (MTPC) (Head Office: Osaka; President & Representative Director, CEO: Masayuki Mitsuka), today announced that a New Drug Application has been submitted to the U.S....
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news